2020-11-16T14:38:46-06:00 2019-12-31 861065772 DELOITTE TAX LLP 50 SOUTH SIXTH STREET MINNEAPOLIS MN 55402 990 2019-01-01 811669175 CHAN ZUCKERBERG BIOHUB INC CHAN 6282003246 499 ILLINOIS ST SAN FRANCISCO CA 94158 VICTOR COLUNGA CFO AND TREASURER 6282003246 2020-11-16 1 ANNA KOLAKALURI P01275237 6123974000 207.153.24.93 2020-11-16 13:31:18 CS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 6632E67FE9E486DD57DB88AC2609154426CCFDCB 2019 2021-01-29 14:40:06Z GAJUS WORTHINGTON 499 ILLINOIS ST SAN FRANCISCO CA 94158 12394101 0 X WWW.CZBIOHUB.ORG X 2016 CA CONDUCT CUTTING EDGE MEDICAL RESEARCH. 7 3 143 0 0 0 7790120 10451256 903318 421941 1103668 1286901 0 83378 9797106 12243476 21552356 22278762 0 0 11891076 18098377 0 0 0 21772296 24924894 55215728 65302033 -45418622 -53058557 521261848 468214819 13961809 13973337 507300039 454241482 X ALLEVIATING HUMAN SUFFERING THROUGH ITS MISSION TO CURE, MANAGE, AND PREVENT ALL DISEASES BY THE END OF THE 21ST CENTURY. 0 0 58173838 22278762 421941 SEE SCHEDULE OIN ITS THIRD FULL YEAR OF EXISTENCE AS A MEDICAL RESEARCH ORGANIZATION, THE CHAN ZUCKERBERG BIOHUB, INC. ("BIOHUB") IS NOW FULLY OPERATIONAL. CONSISTENT WITH OUR MISSION, WE ARE FOCUSING ON SEVERAL LARGE-SCALE SCIENTIFIC PROGRAMS, EACH WITH ITS OWN MULTI-YEAR LIFETIME. THESE TAKE ON THE FOLLOWING FORMS:1. INTERNAL PROJECTS EMPHASIZING BASIC SCIENCE AND SOME CLINICAL RESEARCH FOCUSED ON:A. INFECTIOUS DISEASEB. CELL BIOLOGY2. COMPLEMENTARY, COOPERATIVE RESEARCH PROJECTS THROUGH THE CHAN ZUCKERBERG INVESTIGATORS PROGRAM AND AFFILIATE GIFT PROGRAM.INFECTIOUS DISEASE INITIATIVE HIGHLIGHTS1. IN COLLABORATION WITH THE CHAN ZUCKERBERG INITIATIVE, CREATED AND LAUNCHED IDSEQ, A HYPOTHESIS-FREE GLOBAL SOFTWARE PLATFORM THAT HELPS SCIENTISTS IDENTIFY PATHOGENS IN METAGENOMIC SEQUENCING DATA.2. IN PARTNERSHIP WITH THE BILL AND MELINDA GATES FOUNDATION'S GRAND CHALLENGES EXPLORATIONS COMPETITION, INTRODUCED IDSEQ AND SEQUENCING CAPABILITY FOR INFECTIOUS DISEASE IN CAMBODIA, VIETNAM, MADAGASCAR, KENYA, SOUTH AFRICA, NEPAL, PAKISTAN, THE GAMBIA, MALAWI, AND BRAZIL. THE BIOHUB PROVIDES IN-HOUSE TRAINING FOR GROUPS OF SCIENTISTS FROM EACH OF THESE COUNTRIES AND PROVIDES IN-COUNTRY SUPPORT THROUGH ACCESS TO IDSEQ.3. PROVIDED RESEARCH SUPPORT TO LOCAL CLINICS, INCLUDING UCSF, TO IDENTIFY UNKNOWN PATHOGENS THROUGH OUR RAPID RESPONSE PROGRAM, WHICH UTILIZES BROAD-SCALE IN-HOUSE SEQUENCING.CELL BIOLOGY INITIATIVE HIGHLIGHTS1. CONCLUDED AND PUBLISHED A LARGE-SCALE CELL ATLAS MAPPING PROJECT (TABULA MURIS SENIS) WHICH STUDIES THE TRANSCRIPTOMIC EFFECTS OF AGING ACROSS MANY TISSUES IN MICE. THE DATA AND PREPRINTS ARE ALL PUBLICLY AVAILABLE.2. TAGGED OVER 1,700 HUMAN PROTEINS IN CELL LINES AND CREATED CELLULAR PROTEIN AND INTERACTION DATABASE (OPENCELL).3. CREATED, CONDUCTED AND HOSTED AN INTERNATIONAL GATHERING OF THEORISTS DEDICATED TO BETTER UNDERSTANDING BASIC CELLULAR MECHANISMS.INVESTIGATOR PROGRAM HIGHLIGHTS1. COMMITTED APPROXIMATELY $100 MILLION OVER 5 YEARS TO SUPPORT THE RESEARCH OF 95 FACULTY MEMBERS CONDUCTING RESEARCHERS AT THEIR RESPECTIVE UNIVERSITIES.2. OVER 1,400 PUBLICATIONS AND PREPRINTS TO DATE FROM BIOHUB EMPLOYEES AND BIOHUB INVESTIGATORS. 58173838 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 1 52 0 1 143 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 3 1 0 1 0 0 1 1 1 1 0 0 1 1 1 1 1 0 1 1 1 0 CA X VICTOR COLUNGA CFO & TREASURER 6282003246 499 ILLINOIS ST SAN FRANCISCO CA 94158 X CORI BARGMANN DIRECTOR 5.00 0.00 X 0 0 0 DR JOHN HENNESSY DIRECTOR 5.00 0.00 X 0 0 0 DR PRISCILLA CHAN DIRECTOR 5.00 9.50 X 0 0 0 MARK ZUCKERBERG DIRECTOR 5.00 40.00 X 0 0 0 REID HOFFMAN DIRECTOR 5.00 0.00 X 0 0 0 DR JOSEPH DERISI CO-CHIEF EXECUTIVE 40.00 0.00 X X 770127 0 37874 DR STEPHEN QUAKE CO-CHIEF EXECUTIVE 40.00 0.00 X X 770127 0 37874 GAJUS WORTHINGTON CHIEF OPERATING OFFICER 40.00 0.00 X 629935 0 37878 VICTOR COLUNGA CFO & TREASURER 40.00 0.00 X 602124 0 44179 MAUREEN SHEEHY SECRETARY & LEGAL COUNSEL 40.00 0.00 X 566557 0 43042 BARBARA KOSACZ END 12819 SECRETARY 5.00 0.00 X 0 0 0 JIM KARKANIAS VP, DATA SCIENCES & IT INF 40.00 0.00 X 438407 0 37883 WILLIAM BURKHOLDER DIRECTOR, SCIENTIFIC PROGRAM MANAGEMENT 40.00 0.00 X 246049 0 40457 SONYA ZILKA VP OF HUMAN RESOURCE 40.00 0.00 X 360697 0 19220 RAFAEL GOMEZ-SJOBERG DIRECTOR, BIOENGINEERING 40.00 0.00 X 280261 0 33674 ASTRID HO CONTROLLER 40.00 0.00 X 244219 0 40501 GREG HUBER GROUP LEADER 40.00 0.00 X 223212 0 42083 NORMA NEFF SENIOR CZ BIOHUB FELLOW 40.00 0.00 X 215254 0 17300 5346969 0 431965 58 0 1 0 KILPATRICK TOWNSEND PO BOX 39000 SAN FRANCISCO CA 94139 LEGAL SERVICES 618793 KDINFOTECH 95 S MARKET ST 220 SAN FRANCISCO CA 95113 IT SERVICES 543068 ARNOLD & PORTER KAYE SCHOLER LLP PO BOX 759451 BALTIMORE MD 21275 LEGAL SERVICES 521673 NEXUS CONTINGENT WORKFORCE 4901 MORENA BLVD SUITE 122 SAN DIEGO CA 92117 CONTINGENT WORKFORCE 309419 STEVEN COLLIER JD PHD 6732 MANOR CREST OAKLAND CA 94618 LEGAL SERVICES 291950 13 10451256 816196 10451256 COLLABORATION PROGRAM & LICENSE 541700 421941 421941 421941 1437526 1437526 83378 83378 150625 -150625 -150625 -150625 12243476 421941 0 1370279 22278762 22278762 4302511 1454401 2848110 10804763 10121785 682978 585806 449036 136770 1518263 1146953 371310 887034 689689 197345 1448360 851766 596594 84798 84798 1423169 670271 752898 445494 28979 416515 3759555 3648930 110625 966824 844259 122565 7048989 6495577 553412 337200 309821 27379 230265 225968 4297 15668 15668 2882600 2831478 51122 136518 54389 82129 LAB SUPPLIES 5529659 5529659 MEALS AND ENTERTAINMENT 633785 565257 68528 BUSINESS AND INCOME TAX -106702 -52522 -54180 88712 13712 75000 65302033 58173838 7128195 0 6327016 7662391 92373803 91233639 409089266 353225605 110759 423174 690023 1015036 17040451 5329435 10043898 11711016 641875 2627083 2302083 521261848 468214819 3750747 3858373 10211062 10114964 13961809 13973337 X 95583690 97464133 411716349 356777349 507300039 454241482 521261848 468214819 -53058557 0 X 0 1 X 1 0 X AFFILIATED HOSPITALS OF STANFORD STANFORD CA AFFILIATED HOSPITALS OF UCSF SAN FRANCISCO CA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 306492 69212 237280 16733959 5260223 11473736 11711016 LIABILITY FOR INVESTIGATOR AWARDS 10114964 10114964 X 12394101 150625 150625 12243476 0 12243476 65452658 150625 150625 65302033 0 65302033 PART X, LINE 2: THE BIOHUB IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AS A MEDICAL RESEARCH ORGANIZATION OPERATED IN CONJUNCTION WITH A HOSPITAL AND SECTION 23701D OF THE CALIFORNIA REVENUE AND TAXATION CODE. THE BIOHUB HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2019. PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF ASSETS PART XII, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF ASSETS EUROPE 0 0 PROGRAM SERVICES ATTENDING AND SPEAKING AT CONFERENCES 11264 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES ATTENDING AND SPEAKING AT CONFERENCES. ALSO SITE VISITS FOR TRAINING AND PROJECT SUPPORT. 2091 NORTH AMERICA 0 0 PROGRAM SERVICES ATTENDING AND SPEAKING AT CONFERENCES 1588 SOUTH ASIA 0 0 PROGRAM SERVICES ATTENDING AND SPEAKING AT CONFERENCES. ALSO SITE VISITS FOR TRAINING AND PROJECT SUPPORT. 27293 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES ATTENDING AND SPEAKING AT CONFERENCES. ALSO SITE VISITS FOR TRAINING AND PROJECT SUPPORT. 37447 EUROPE 0 0 PROGRAM SERVICES CONSULTING 49430 0 0 0 0 0 0 129113 0 129113 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 STANFORD 3145 PORTER DRIVE PALO ALTO CA 94304 941156365 501(C)(3) 9107289 SCIENTIFIC AND MEDICAL RESEARCH UC SAN FRANCISCO PO BOX 0248 SAN FRANCISCO CA 94143 946036493 501(C)(3) 8550382 SCIENTIFIC AND MEDICAL RESEARCH UC BERKELEY 2195 HEARST AVE RM 120 MC 1104 BERKELEY CA 94720 946002123 501(C)(3) 4621091 SCIENTIFIC AND MEDICAL RESEARCH 3 0 PART I, LINE 2 THE BIOHUB WILL OBLIGATE THE USE OF THE GIFT FUNDS ONLY FOR THE PURPOSE FOR WHICH THE BIOHUB MAKES THE AWARD. THE BIOHUB WILL REQUIRE PERIODIC WRITTEN REPORTS CONCERNING THE USE OF THE GIFT AS APPROPRIATE AND RETAIN FOR THE BIOHUB THE RIGHT TO WITHHOLD OR RECOVER FUNDS IN CASES OF MISUSE AS APPROPRIATE. FROM TIME TO TIME, THE BIOHUB WILL MAKE DISCRETIONARY GIFTS TO 501(C)(3) ORGANIZATIONS WITHOUT THE NEED FOR A WRITTEN PROPOSAL. X X X 0 0 0 0 0 0 0 1 0 DR JOSEPH DERISI CO-CHIEF EXECUTIVE 548375 0 221200 0 552 0 7074 0 26175 0 803376 0 0 0 DR STEPHEN QUAKE CO-CHIEF EXECUTIVE 548375 0 221200 0 552 0 7074 0 26175 0 803376 0 0 0 GAJUS WORTHINGTON CHIEF OPERATING OFFICER 448375 0 181200 0 360 0 7078 0 26175 0 663188 0 0 0 VICTOR COLUNGA CFO & TREASURER 426175 0 173200 0 2749 0 12500 0 27054 0 641678 0 0 0 MAUREEN SHEEHY SECRETARY & LEGAL COUNSEL 401525 0 164000 0 1032 0 9592 0 28825 0 604974 0 0 0 JIM KARKANIAS VP, DATA SCIENCES & IT INF 335375 0 102000 0 1032 0 7083 0 26175 0 471665 0 0 0 WILLIAM BURKHOLDER DIRECTOR, SCIENTIFIC PROGRAM MANAGEM 203565 0 41711 0 773 0 9588 0 26106 0 281743 0 0 0 SONYA ZILKA VP OF HUMAN RESOURCE 271360 0 83077 0 6260 0 11836 0 6631 0 379164 0 0 0 RAFAEL GOMEZ-SJOBERG DIRECTOR, BIOENGINEERING 232177 0 47760 0 324 0 9500 0 21384 0 311145 0 0 0 ASTRID HO CONTROLLER 199353 0 42088 0 2778 0 9500 0 26364 0 280083 0 0 0 GREG HUBER GROUP LEADER 187841 0 34644 0 727 0 11355 0 26100 0 260667 0 0 0 NORMA NEFF SENIOR CZ BIOHUB FELLOW 180515 0 32789 0 1950 0 10664 0 6307 0 232225 0 0 0 PART I, LINE 7 INCENTIVE COMPENSATION WAS PROVIDED TO CERTAIN PERSONS LISTED ON PART VII OF THE FORM 990. INCENTIVE COMPENSATION WAS PAID BASED ON A FIXED PERCENTAGE OF BASE COMPENSATION, PLUS AN ADDITIONAL DISCRETIONARY PERCENTAGE SUBJECT TO BOARD APPROVAL. CHAN ZUCKERBERG INITIATIVE LLC (CZI) ENTITY MANAGED BY DIRECTORS MARK ZUCKERBERG AND PRISCILLA CHAN 421942 COLLABORATION REVENUE PAID FROM CZI TO BIOHUB 0 X COMMON AREA MAINTENANCE 1 683551 FAIR MARKET VALUE X EQUIPMENT 1 114055 FAIR MARKET VALUE X FURNITURE & FIXTURES 1 18590 FAIR MARKET VALUE 0 0 0 0 PART I, COLUMN (B): COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS FORM 990, PART VI, SECTION A, LINE 2 DR. CHAN (DIRECTOR) AND MR. ZUCKERBERG (DIRECTOR) HAVE A FAMILY RELATIONSHIP. CORI BARGMANN, DR. CHAN AND MR. ZUCKERBERG HAVE A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE AMENDED TO STATE: THE PROPERTY OF THE CORPORATION IS IRREVOCABLY DEDICATED TO CHARITABLE OR SCIENTIFIC PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE CODE. UPON THE DISSOLUTION OR WINDING UP OF THE CORPORATION, THE ASSETS OF THE CORPORATION REMAINING AFTER PAYMENT, OR PROVISION FOR PAYMENT, OF ALL DEBTS AND LIABILITIES OF THE CORPORATION SHALL BE DISTRIBUTED TO A NONPROFIT FUND, FOUNDATION, OR CORPORATION WHICH IS ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE OR SCIENTIFIC PURPOSES AND WHICH HAS ESTABLISHED ITS TAX-EXEMPT STATUS UNDER SECTION 501(C)(3) OF THE CODE, OR SHALL BE DISTRIBUTED TO THE FEDERAL GOVERNMENT, OR TO A STATE OR LOCAL GOVERNMENT, FOR A PUBLIC PURPOSE. FORM 990, PART VI, SECTION A, LINE 7A THE CHAN ZUCKERBERG INITIATIVE, LLC DESIGNATES TWO BOARD OF DIRECTORS (DESIGNATED DIRECTORS). SUCH DESIGNATED DIRECTORS APPROVE THE APPOINTING, ELECTING, OR REMOVING OF ANY DIRECTOR OF THE ORGANIZATION INCLUDING THE FILLING OF ANY VACANCY OF THE BOARD. FORM 990, PART VI, SECTION A, LINE 7B GOVERNANCE DECISIONS ARE SUBJECT TO APPROVAL BY THE TWO DESIGNATED DIRECTORS INCLUDING: -CHANGING THE NATURE OR SCOPE OF THE MISSION. -CHANGING, SELLING OR LICENSING THE NAME OF THE CORPORATION. -APPROVING OR PERMITTING THE USE OF OTHER EXPLOITATION OF THE NAME OF THE CORPORATION BY ANY PARTY, OTHER THAN THE DESIGNATOR, ANY AFFILIATE OR AFFILIATED ENTITY OF THE DESIGNATOR AND, SOLELY IN CONNECTION WITH THE CORPORATION'S ACTIVITIES IN FURTHERANCE OF THE MISSION. -APPOINTING, ELECTING OR REMOVING ANY DIRECTOR OF THE CORPORATION AND FILLING OF ANY VACANCY OF THE BOARD. -INCREASING OR DECREASING THE NUMBER OF DIRECTOR SEATS ON THE BOARD. -APPOINTING, ELECTING OR REMOVING THE CHAIRPERSON -ACCEPTING CONTRIBUTIONS FROM ANY PARTY OTHER THAN FROM THE DESIGNATOR, ANY AFFILIATE OR AFFILIATED ENTITY OF THE DESIGNATOR, OR ANY DONOR ADVISED FUND IN WHICH THE DESIGNATION OR AFFILIATE HAVE ADVISORY PRIVILEGES. OTHER PARTY FUNDING CAN BE ACCEPTED IF THE DESIGNATOR FUNDING SOURCE HAS A MATERIAL BREACH AND ADDITIONAL FUNDING IS NEEDED. -APPROVAL OR EFFECTING OF A MATERIAL SALE OF ASSETS OR MERGER OF THE ORGANIZATION OR CONVERSION INTO ANOTHER FORM OF ENTITY. -APPROVAL OF ACTION CAUSING CHANGE FROM EXEMPT STATUS UNDER 501(A) OF THE CODE. -APPROVAL FOR COMMENCING BANKRUPTCY, INSOLVENCY OR RELIEF OF DEBTORS. -APPROVAL, PERMITTING OR EFFECTING ANY TRANSACTION TO LIQUIDATE, WIND UP OR DISSOLVE THE CORPORATION. -APPROVAL FOR CHANGE TO ORGANIZATION DOCUMENTS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY OUR TAX CONSULTANTS. THE DRAFT IS REVIEWED BY THE CFO OF THE ORGANIZATION. THE FORM 990 IS THEN MADE AVAILABLE TO THE BOARD PRIOR TO THE 990 BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C EACH COVERED PERSON MUST DISCLOSE IN WRITING TO THE CHIEF CONFLICTS OFFICER EACH OF HIS OR HER CONFLICTS OF INTEREST, INCLUDING FINANCIAL INTERESTS, WHEN THEY JOIN THE COMPANY. TO ENSURE THAT POTENTIAL CONFLICTS OF INTEREST AND CONFLICTS OF COMMITMENT ARE DISCLOSED, EACH COVERED PERSON IS REQUIRED TO UPDATE THEIR DISCLOSURE PERIODICALLY THROUGHOUT THE YEAR AT ANY TIME WHEN HIS OR HER PREVIOUSLY DISCLOSED FINANCIAL INTERESTS CHANGE OR A NEW POTENTIAL CONFLICT OF COMMITMENT OR CONFLICT OF INTEREST ARISES. IN ADDITION, CERTAIN EMPLOYEES AT THE LEVEL OF GROUP OR PLATFORM LEADER OR ABOVE ARE REQUIRED TO FILE UPDATED DISCLOSURE STATEMENTS EACH YEAR. THE BOARD OF DIRECTORS APPROVED THE CONFLICT OF COMMITMENT AND CONFLICT OF INTEREST POLICY FOR THE COMPANY, WHICH OUTLINES THE MECHANISMS FOR IMPLEMENTING THE POLICY. THE CHIEF CONFLICTS OFFICER OR IN SOME INSTANCES, THE BOARD OF DIRECTORS OR A COMMITTEE DESIGNATED BY THE BOARD IS RESPONSIBLE FOR INTERPRETING BOTH CONFLICTS OF COMMITMENT AND CONFLICTS OF INTEREST UNDER THE POLICY. THE CHIEF CONFLICTS OFFICER'S PRIMARY RESPONSIBILITY IS DETERMINING WHETHER A CONFLICT OF COMMITMENT OR CONFLICT OF INTEREST EXISTS AND, IF SO, WHETHER THE PROPOSED ACTIVITY OR THE TRANSACTION OR ARRANGEMENT GIVING RISE TO THE CONFLICT IS IN THE BEST INTERESTS OF THE BIOHUB AND CAN PROCEED IN A MANNER THAT PROTECTS THE BIOHUB'S FINANCIAL, SCIENTIFIC, AND REPUTATIONAL INTERESTS. WHEN A COVERED PERSON DISCLOSES AN ACTUAL OR POTENTIAL CONFLICT OF COMMITMENT OR CONFLICT OF INTEREST UNDER THIS POLICY, THE CHIEF CONFLICTS OFFICER WILL FOLLOW THE REVIEW PROCEDURES OUTLINED IN THE POLICY. A COVERED PERSON MAY NOT ENGAGE IN ANY ACTIVITY THAT GIVES RISE TO A CONFLICT OF COMMITMENT OR A CONFLICT OF INTEREST WITHOUT RECEIVING THE APPROVAL(S) REQUIRED IN THIS POLICY. WITH RESPECT TO ANY CONFLICT OF INTEREST, THE COVERED PERSON WILL BE RECUSED FROM ALL DECISIONS INVOLVING THE ACTIVITY GIVING RISE TO THE CONFLICT, AND THE CHIEF CONFLICTS OFFICER, THE BOARD OF DIRECTORS, OR A COMMITTEE DESIGNED BY THE BOARD WILL DETERMINE WHETHER TO PROCEED WITH THE ACTIVITY NOTWITHSTANDING THE CONFLICT. IF THE COVERED PERSON INVOLVED IN THE POTENTIAL OR ACTUAL CONFLICT UNDER REVIEW IS AN OFFICER OF THE BIOHUB, THE CONFLICT REVIEW PROCEDURES WILL BE PERFORMED BY THE BOARD OF DIRECTORS OR A COMMITTEE DESIGNATED BY THE BOARD, ASSISTED BY THE CHIEF CONFLICTS OFFICERAND, IF REQUESTED BY THE BOARD OR COMMITTEE, OUTSIDE COUNSEL. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE OF THE BOARD REVIEW AND APPROVE THE COMPENSATION OF THE ORGANIZATION'S CO-CHIEF EXECUTIVES, OFFICERS AND KEY EMPLOYEES. THE PROCESS INCLUDES A REVIEW OF THE COMPENSATION AGAINST CURRENT COMPARABILITY DATA SURVEY PREPARED BY AN INDEPENDENT COMPENSATION CONSULTANT. THE APPROVAL PROCESS IS DOCUMENTED CONTEMPORANEOUSLY. THE MOST RECENT COMPARABILITY DATA STUDY WAS COMPLETED IN 2018 AND WAS USED TO SET 2019 COMPENSATION. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, DOCUMENTS THAT ARE REQUIRED BY LAW TO BE AVAILABLE FOR PUBLIC INSPECTION WILL BE MADE AVAILABLE. FORM 990, PART VI, SECTION B, LINE 16B BIOHUB HAS EXECUTED CERTAIN WRITTEN COLLABORATION AGREEMENTS IN FURTHERANCE OF ITS EXEMPT MISSION. SUCH CONTRACTS ARE EXECUTED ON TERMS THAT ARE AT ARM'S LENGTH OR MORE FAVORABLE TO BIOHUB. PART VII, SECTION A WHERE 40 HOURS IS LISTED AS HOURS OF SERVICE IN RESPECT OF AN INDIVIDUAL, THIS IS BASED ON AN ESTIMATED FULL-TIME WORK WEEK. ACTUAL HOURS DEVOTED BY THE INDIVIDUAL MAY VARY SIGNIFICANTLY, AND MAY EXCEED THE 40 HOUR ESTIMATE. CHAN ZUCKERBERG ADVOCACY 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 813742328 SOCIAL WELFARE CA 501(C)(4) N/A N/A 0 CHAN ZUCKERBERG FOUNDATION 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 455002209 GRANTMAKING CA 501(C)(3) PF N/A 0 THE PRIMARY SCHOOL LAB 1765 E BAYSHORE RD SUITE A2 E PALO ALTO CA 94303 364858582 SOCIAL WELFARE CA 501(C)(4) N/A N/A 0 THE PRIMARY SCHOOL - EAST PALO ALTO 951 OCONNER STREET E PALO ALTO CA 94303 473334579 EDUCATION CA 501(C)(3) 170(B)(1)(A)(II) SCH N/A 0 OPENNESS FOUNDATION 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 270889149 GRANTMAKING CA 501(C)(3) PF N/A 0 TLP 818 W 7TH ST SUITE 930 LOS ANGELES CA 90017 352645251 EDUCATION CA 501(C)(3) 509(A)(1) N/A 0 FWDUS EDUCATION FUND INC PO BOX 34506 WASHINGTON DC DE 20043 820962378 EDUCATE THE PUBLIC ABOUT IMMIGRATION AND CRIMINAL JUSTICE POLICY AND REFORM DE 501(C)(3) 509(A)(1) 170(B)(1)( FWDUS INC 0 FWDUS INC PO BOX 34506 WASHINGTON DC DE 20043 462223015 ADVOCATE FOR IMMIGRATION AND CRIMINAL JUSTICE REFORM DE 501(C)(4) N/A N/A 0 FACEBOOK INC 1601 WILLOW ROAD MENLO PARK CA 94025 201665019 SOCIAL MEDIA SERVICE COMPANY DE N/A C 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 FORM 990, SCHEDULE R, PART II AND PART IV ONE OF THE MANAGERS OF CHAN ZUCKERBERG INITIATIVE, LLC ("CZI") ALSO HAS A CONTROLLING INTEREST IN SEVERAL PASSIVE INVESTMENT VEHICLES. THESE INVESTMENT VEHICLES, THE TAX-EXEMPT ENTITIES DISCLOSED UNDER PART II ABOVE, AND FACEBOOK AS DISCLOSED UNDER PART IV ABOVE, MAY TECHNICALLY BE CONSIDERED "RELATED ORGANIZATIONS" OF THE BIOHUB FOR IRS FORM 990 REPORTING PURPOSES THROUGH THEIR RELATIONSHIP WITH ONE OF CZI'S MANAGERS, GIVEN CZI'S RELATIONSHIP WITH THE BIOHUB. EACH OF THESE DISCLOSED ENTITIES IS OTHERWISE UNAFFILIATED WITH AND DOES NOT CONTROL THE BIOHUB, AND THE BIOHUB'S DATA IS NOT SOLD OR SHARED WITH FACEBOOK, THE PASSIVE INVESTMENT VEHICLES, OR ANY OF THE DISCLOSED TAX-EXEMPT ENTITIES.